Latest news
IPO Preview | Re-filing with HKEX: With Cash Running Low, What Supports Xinji Pharmaceuticals' HK$1.5 Billion Valuation? - MoomooMoomoo · Sun, 09 Aug 2026 16:31:13 GMTCITIC Securities: Maintains 'Outperform Market' rating on the innovative pharmaceuticals sector, recommends positioning along three key themes. - MoomooMoomoo · Sun, 09 Aug 2026 02:40:23 GMTThe Race to Come Up With the Next Big Sleep Drug -- WSJ - MoomooMoomoo · Fri, 07 Aug 2026 01:26:43 GMTPress Release: Biogen Completes Acquisition of RayThera Inc. - MoomooMoomoo · Thu, 06 Aug 2026 22:15:00 GMTPress Release: Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - MoomooMoomoo · Thu, 06 Aug 2026 20:01:00 GMTFDA Provides Further Regulatory Guidance to Acurx Pharmaceuticals for the Ibezapolstat Clinical Development Program, Including the Potential for a Single-Phase 3-Trial Registration Plan and a Trial Design to Support Both Treatment and Reduction of... - MoomooMoomoo · Mon, 03 Aug 2026 12:00:00 GMTNovo Nordisk's Stock Slumps After Failed Trial - Adding to the Company's Woes - MoomooMoomoo · Fri, 31 Jul 2026 13:54:00 GMTNovo Nordisk Shares Drop After Drug Candidate Fails in Cardiovascular Trial - MoomooMoomoo · Fri, 31 Jul 2026 11:49:46 GMT